FDA exec takes seat on AAMI standards program

Brian Dunham | October 04, 2011 | Health Exec | Digital Transformation

The Association for the Advancement of Medical Instrumentation (AAMI) has named Carol Herman, an FDA official, as its new senior vice president of standards and policy programs.

Herman currently serves as director of the standards program at the FDA’s Center for Devices and Radiological Health. She will leave the post at the end of the year and join AAMI on Jan. 1, replacing retiring standards leader Theresa Zuraski, according to an AAMI statement. Zuraski has been with AAMI since 1988 and will continue to work for the association as a consultant.

Herman started at the FDA in 1978, serving in various roles until taking her present post in 2000.

Brian Dunham

Around the web

Cardiovascular Business

Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.

AI in Healthcare

A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business

FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

FDA exec takes seat on AAMI standards program

Related Content

Around the web